Combination of High-Dose Parenteral Ascorbate (Vitamin C) and Alpha-Lipoic Acid Failed to Enhance Tumor-Inhibitory Effect But Increased Toxicity in Preclinical Cancer Models.

Autor: Chen, Ping¹ (AUTHOR), Lamson, Davis² (AUTHOR), Anderson, Paul³ (AUTHOR), Drisko, Jeanne⁴ (AUTHOR), Chen, Qi¹ (AUTHOR) Qchen@kumc.edu

Publikováno v: Clinical Medicine Insights: Oncology. 10/31/2024, p1-11. 11p.

Potential deprescribing indications for antidepressants between 2012 and 2019: repeated cross-sectional analysis in two Scottish health boards.

Autor: Brisnik, Vita^1,2 (AUTHOR), Rottenkolber, Marietta¹ (AUTHOR), Vukas, Jochen^1,2 (AUTHOR), Schechner, Miriam¹ (AUTHOR), Lukaschek, Karoline^1,2 (AUTHOR), Jung-Sievers, Caroline^2,3,4 (AUTHOR), Gensichen, Jochen^1,2 (AUTHOR), Thiem, Ulrich⁵ (AUTHOR), Drey, Michael⁶ (AUTHOR), Krüger, Nils^7,8 (AUTHOR), Mair, Alpana⁹ (AUTHOR), Guthrie, Bruce¹⁰ (AUTHOR), Fischer, Sebastian^1,11 (AUTHOR), Dreischulte, Tobias^1,2 (AUTHOR) tobias.dreischulte@med.uni-muenchen.de, Falkai, Peter (AUTHOR), Henningsen, Peter (AUTHOR), Bühner, Markus (AUTHOR), Krcmar, Helmut (AUTHOR), Pitschel-Walz, Gabriele (AUTHOR), Schneider, Antonius (AUTHOR)

Publikováno v: BMC Medicine. 9/11/2024, Vol. 22 Issue 1, p1-14. 14p.

Addressing Polypharmacy: Developing Public-Facing Resources Through Storytelling-Based Co-Design.

Autor: Thomson, Alison¹ (AUTHOR) a.thomson@qmul.ac.uk, Fudge, Nina¹ (AUTHOR), Van Blarikom, Esca¹ (AUTHOR), Swinglehurst, Deborah¹ (AUTHOR)

Publikováno v: International Journal of Qualitative Methods. 8/13/2024, p1-11. 11p.

Pharmacology of beta-L-thymidine and beta-L-2'-deoxycytidine in HepG2 cells and primary human hepatocytes: relevance to chemotherapeutic efficacy against hepatitis B virus

Autor: Jean Louis Imbach, J.-P. Sommadossi, Gilles Gosselin, E. G. Bridges, B. Hernandez-Santiago, David Dukhan, Claire Pierra, Abdesslem Faraj, Martin L. Bryant, Erika Cretton-Scott, Laurent Placidi, J. Rodriguez-Orengo

Publikováno v: Antimicrobial agents and chemotherapy. 46(6)

β- l -Thymidine ( l -dT) and β- l -2′-deoxycytidine ( l -dC) are potent and highly specific inhibitors of hepatitis B virus (HBV) replication both in vivo and in vitro (50% effective concentrations, 0.19 to 0.24 μM in 2.2.15 cells). The intracel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbcffd3b0caaf5b8f9490f7db540f48e
https://pubmed.ncbi.nlm.nih.gov/12019082

Survey of Potential Drug Interactions, Use of Non-Medical Health Products, and Immunization Status among Patients Receiving Targeted Therapies.

Autor: Rajj, Réka¹ (AUTHOR) fittler.andras@pte.hu, Schaadt, Nóra² (AUTHOR), Bezsila, Katalin¹ (AUTHOR), Balázs, Orsolya¹ (AUTHOR), Jancsó, Marcell B.¹ (AUTHOR), Auer, Milán¹ (AUTHOR), Kiss, Dániel B.² (AUTHOR), Fittler, András¹ (AUTHOR), Somogyi-Végh, Anna² (AUTHOR), Télessy, István G.¹ (AUTHOR), Botz, Lajos^1,2 (AUTHOR), Vida, Róbert Gy.¹ (AUTHOR) vida.robert@pte.hu

Publikováno v: Pharmaceuticals (14248247). Jul2024, Vol. 17 Issue 7, p942. 19p.